Depression linked to E-cigarettes and cigarette use among college students

Jul.15.2022
Depression linked to E-cigarettes and cigarette use among college students
Depression linked to tobacco use among college students, according to study in Psychiatry Research Communications.

A study published in the Journal of Psychiatric Research found a positive correlation between depression and tobacco product use, including electronic and traditional cigarettes, among college students.


This study analyzed data from the Fall 2020 cohort of the Healthy Minds Study, which collected information on the psychological health of undergraduate and graduate students, as well as sociodemographic covariates and other relevant factors. The online survey was distributed to 36 universities across the United States between September and December 2020. Five of these universities included drug use in the survey, resulting in a sample size of 2,115 for this study.


Attendees reported on individuals who exclusively use e-cigarettes, exclusively use traditional cigarettes, and those who use a combination of both. The symptoms of depression were measured using the Patient Health Questionnaire-9 (PHQ-9) for the participants. The PHQ-9 questionnaire scores the answers on a scale ranging from 0 to 27, with scores above 5 indicating possible depression.


The study measures societal norms surrounding tobacco use and perceptions of risks associated with tobacco use. In order to gauge societal norms, participants were asked to estimate the percentage of college students who smoke. Responses to questions about tobacco risks were measured on a scale of 1 to 4, with 1 indicating "no risk" and 4 indicating "high risk.


Using logistic regression analysis, this study examines the social norms of tobacco use among individuals with symptoms of depression, perceived risk of smoking, and those who use both traditional cigarettes and e-cigarettes.


The average age of participants was 23.41±7.84 years, with 43.8% being female and 85.6% being white. Participants reported that in the past 30 days, 22.38% only used e-cigarettes, 7.89% only used traditional cigarettes, and 2.72% used a combination of both.


A study has found that 33.1% of participants met the criteria for possible depression, with an average score of 8.00 ± 6.33. The levels of depression were higher among all groups who used tobacco products: those who only used e-cigarettes (OR, 1.08; 95%CI, 1.06-1.10), those who only smoked traditional cigarettes (OR, 1.09; 95%CI, 1.06-1.12), and those who used both (OR, 1.05; 95%CI, 1.00-1.10).


Participants reported medium risks associated with smoking and vaping, with average scores of 3.26 ± 1.01 and 2.85 ± 0.98, respectively. The perceived social norms related to the use of electronic cigarettes (OR, 1.01; 95% CI 1.00-1.02) and cigarettes (OR, 1.02; 95% CI, 1.00-1.03) were higher and associated with increased use of these tobacco products.


Most participants in the study were white students, so the results may not be representative. Although the researchers emphasized the confidentiality of the responses, students may have underreported their tobacco use.


Overall, researchers have concluded that there is a link between depression and both e-cigarettes and traditional cigarettes. They have found that the likelihood of using e-cigarettes and traditional cigarettes is positively associated with the likelihood of depression.


The researchers stated that gaining further knowledge on psychosocial and mental health related factors could provide valuable information in understanding the smoking habits and associated risks in college students. This understanding can guide the development of smoking cessation policies.


I'm sorry, but without any text to translate, I cannot provide a response.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia's digital labeling regime for reusable e-cigarettes and similar personal vaping devices entered its first mandatory phase in September 2026. From September 1, manufacturers, importers and other market participants must register with the national Chestny ZNAK tracking system. From December 1, newly manufactured and imported covered devices will be required to carry digital identification codes and be reported as entering circulation. Russia has also issued new operational guidance for imports, marking the transition from a voluntary pilot to phased mandatory implementation.
Sep.15
Japanese Addiction Psychiatrist Says Complete Abstinence Is Not Always the Goal of Harm Reduction | 2Firsts Interview
Japanese Addiction Psychiatrist Says Complete Abstinence Is Not Always the Goal of Harm Reduction | 2Firsts Interview
Complete abstinence is not always the goal of addiction treatment under a harm-reduction approach, Japanese psychiatrist Tomohiro Shirasaka told 2Firsts in Manila. In the interview, he discussed patients' quality of life, Japan's shift towards heated tobacco products, and the challenges of quitting smoking for people with mental illness. Drawing on addiction treatment work in the Philippines, he advocated support rather than punishment and questioned whether fear-based health warnings effectively address the reasons people continue smoking.
Nov.10
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Vaping prevalence in Great Britain edged down to 9.9% in 2025 from 10.0% in 2024, with the number of adult users holding at approximately 5.4 million for a second consecutive year, according to the Office for National Statistics (ONS). E-cigarette use had risen from 6.4% in 2020 to 10.0% in 2024, when it exceeded cigarette smoking prevalence for the first time. Cigarette smoking continued to decline to 8.7% in 2025, widening the gap to 1.2 percentage points. Daily vaping declined slightly, while usage among adults aged 25–34 increased despite falling rates in other age groups.
DATA
Oct.14
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
British American Tobacco (BAT)'s VELO brand launched the VELO WRKS nicotine pouch range in Sweden on November 2, 2026. The initial release features three Dual Can variants, each containing two separate flavours in a dual-compartment container. Each can holds 20 slim pouches with 8mg of nicotine per pouch and retails for SEK 52.99. According to VELO, the first release, Drop 1, is limited to 75,000 cans and will remain available until February 2027 or while stocks last. VELO positions WRKS as a platform for testing new product concepts and has introduced an online consumer feedback survey. EU trademark records show BAT applied to register VELO WRKS in March 2026 under Class 34, covering nicotine pouches, e-cigarettes, heated tobacco products and other tobacco-related goods.
product
Nov.03